Urothelial carcinoma after cyclophosphamide therapy.

Abstract	We report a case of transitional cell carcinoma of the bladder after cyclophosphamide therapy for chronic lymphocytic leukemia. Urologic evaluation and histologic confirmation occurred only after low grade tumor cells were identified in multiple urine samples. Malignant cells can be distinguished from drug effect in urinary specimens from patients treated with cyclophosphamide and all such cases should include regular cytologic evaluations.
Authors	S M Moinuddin, D W Upton
Journal	The Journal of urology (J Urol) Vol. 129 Issue 1 Pg. 143-4 (Jan 1983) ISSN: 0022-5347 [Print] United States
PMID	6827670 (Publication Type: Case Reports, Journal Article)
Chemical References	Cyclophosphamide
Topics	Aged Carcinoma, Transitional Cell (chemically induced, pathology) Cyclophosphamide (adverse effects) Humans Leukemia, Lymphoid (drug therapy) Male Neoplasms, Multiple Primary Urinary Bladder Neoplasms (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!